We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.91%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$117B
AUM Growth
-$6.8B
(-5.5%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-1.67%
Top 10 Holdings %
Top 10 Hldgs %
30.2%
Holding
4,248
New
63
Increased
1,950
Reduced
1,821
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$162M |
| 2 |
Vertiv
VRT
|
+$52.4M |
| 3 |
Palo Alto Networks
PANW
|
+$34.3M |
| 4 |
Waters Corp
WAT
|
+$21.5M |
| 5 |
Pinnacle Financial Partners Inc
PNFP
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$607M |
| 2 |
Apple
AAPL
|
+$186M |
| 3 |
Microsoft
MSFT
|
+$139M |
| 4 |
Meta Platforms (Facebook)
META
|
+$89.6M |
| 5 |
NVIDIA
NVDA
|
+$74.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.6% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 10.32% |
| 4 | Industrials | 10.12% |
| 5 | Healthcare | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Arhaus
ARHS
$1.13B
| $437K | ﹤0.01% |
64,395
-1,018
| -2% | -$9.24K |
|
2527
Rapid7
RPD
$652M
| $436K | ﹤0.01% |
79,176
-6,103
| -7% | -$56.1K |
|
2528
Luxfer Holdings
LXFR
$462M
| $435K | ﹤0.01% |
35,753
-460
| -1% | -$6.4K |
|
|
HPP
2529
Hudson Pacific Properties
HPP
$839M
| $435K | ﹤0.01% |
73,601
+12,014
| +20% | +$92.3K |
|
|
BBBY
2530
Bed Bath & Beyond
BBBY
$495M
| $434K | ﹤0.01% |
93,550
-2,265
| -2% | -$12.7K |
|
|
TECX
2531
Tectonic Therapeutic
TECX
$592M
| $434K | ﹤0.01% |
14,027
-169
| -1% | -$4.16K |
|
2532
Aura Biosciences
AURA
$756M
| $433K | ﹤0.01% |
64,720
-314
| -0.5% | -$1.8K |
|
2533
Fulgent Genetics
FLGT
$569M
| $432K | ﹤0.01% |
27,145
-1,518
| -5% | -$32.9K |
|
2534
iHeartMedia
IHRT
$549M
| $429K | ﹤0.01% |
147,069
-6,817
| -4% | -$22.6K |
|
|
TEF
2535
DELISTED
Telefonica
TEF
| $429K | ﹤0.01% |
+98,827
| New | +$387K |
|
2536
Akebia Therapeutics
AKBA
$343M
| $427K | ﹤0.01% |
306,926
-10,493
| -3% | -$14.4K |
|
2537
Cadiz
CDZI
$268M
| $426K | ﹤0.01% |
86,715
-1,712
| -2% | -$9.36K |
|
2538
Fresenius Medical Care
FMS
$13.3B
| $423K | ﹤0.01% |
18,734
+1,394
| +8% | +$32K |
|
2539
Aveanna Healthcare
AVAH
$2.1B
| $422K | ﹤0.01% |
65,543
-11,509
| -15% | -$89K |
|
|
LBRX
2540
LB Pharmaceuticals
LBRX
$1.03B
| $422K | ﹤0.01% |
17,103
+820
| +5% | +$18.9K |
|
2541
Dave & Buster's
PLAY
$357M
| $421K | ﹤0.01% |
38,894
-49,928
| -56% | -$798K |
|
2542
Hackett Group
HCKT
$251M
| $421K | ﹤0.01% |
32,349
-103,626
| -76% | -$1.66M |
|
|
KREF
2543
KKR Real Estate Finance Trust
KREF
$473M
| $420K | ﹤0.01% |
68,691
-60,119
| -47% | -$439K |
|
|
CDNL
2544
Cardinal Infrastructure Group
CDNL
$1.29B
| $417K | ﹤0.01% |
+10,522
| New | +$305K |
|
2545
Grupo Cibest SA
CIB
$20.6B
| $416K | ﹤0.01% |
5,710
-55
| -1% | -$4.05K |
|
2546
Genesco
GCO
$411M
| $415K | ﹤0.01% |
14,320
-887
| -6% | -$25.5K |
|
|
MPLT
2547
MapLight Therapeutics
MPLT
$632M
| $414K | ﹤0.01% |
20,368
+6,726
| +49% | +$120K |
|
2548
Lexeo Therapeutics
LXEO
$378M
| $414K | ﹤0.01% |
72,082
+2,713
| +4% | +$19.2K |
|
2549
Safe Bulkers
SB
$772M
| $413K | ﹤0.01% |
65,237
-5,154
| -7% | -$30.1K |
|
2550
Designer Brands
DBI
$293M
| $409K | ﹤0.01% |
71,886
-1,663
| -2% | -$11.2K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, RhumbLine Advisers held 4,248 positions worth $117B, down 5.5% from $124B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.9%. RhumbLine Advisers opened 63 new positions and exited 101, leaving the 4,248-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q1 2026 buy was Versant Media Group: 361,319 shares worth $13.4M.
- RhumbLine Advisers added most to Marsh in Q1 2026, an estimated $162M increase.
- RhumbLine Advisers's biggest Q1 2026 reduction was iShares Russell 3000 ETF, cutting an estimated $607M.
- RhumbLine Advisers fully exited Everpure Inc in Q1 2026, selling an estimated $58.7M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $117B portfolio in Q1 2026.
- RhumbLine Advisers opened 63 new positions and closed 101 in Q1 2026.
- RhumbLine Advisers's portfolio value fell 5.5% quarter-over-quarter to $117B.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.